Quantcast
Published On: Thu, Dec 12th, 2013

Princeton vaccinates 4,361 with Bexsero with one clinic day left

Princeton University said Wednesday that more than 4,300 people received the first dose of the two-dose series of the meningococcal serogroup B vaccine after three days of clinic operations.

meningococcus

Neisseria meningitidis
Image/CDC

As of Wednesday night, the total number vaccinated with Novartis’ Bexsero, the unlicensed for use in the US vaccine, was 4,361 with today being the last clinic day.

The vaccine clinic, held in the Frist Campus Center multipurpose room, will close at 8 pm tonight.

The meningococcal meningitis B outbreak that sickened eight since March prompted federal health authorities to allow the unlicensed vaccine use at the New Jersey campus.

Bexsero is licensed for use in Europe and Australia, but not the United States. The CDC and the Food and Drug Administration have allowed the use of this vaccine for this particular situation at Princeton. The vaccines will be administered by Maxim Health Systems, which also runs the annual flu vaccine clinic on campus.

The second shot in the series will be offered in February, according to Princeton officials.

Meningococcal meningitis is caused by a bacteria called Neisseria meningitidis that can infect the lining of the brain and spinal cord. There are a few different types or strains of Neisseria meningitidis. In the US, types B, C and Y cause the majority of disease.

In the US, approximately 800 to 1,500 people are infected with meningococcal meningitis and 120 die from the disease per year. About one of every five survivors lives with permanent disabilities, such as seizures, amputations, kidney disease, deafness, brain damage and psychological problems.

For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page

Looking for a job in health care? Check here to see what’s available

 

 

On the DISPATCH: Headlines  Local  Opinion

Subscribe to Weekly Newsletter

* indicates required
/ ( mm / dd ) [ALL INFO CONFIDENTIAL]

About the Author

- Writer, Co-Founder and Executive Editor of The Global Dispatch. Robert has been covering news in the areas of health, world news and politics for a variety of online news sources. He is also the Editor-in-Chief of the website, Outbreak News Today and hosts the podcast, Outbreak News Interviews on iTunes, Stitcher and Spotify Robert is politically Independent and a born again Christian Follow @bactiman63

Tags
Displaying 3 Comments
Have Your Say
  1. Novartis releases results of Bexsero campaign | Outbreak News Today says:

    […] doses have been shipped worldwide[9]. Bexsero was also recently provided in the US to students at Princeton University and the University of California, Santa Barbara (UCSB) under a treatment Investigational New […]

  2. Novartis release results of Bexsero campaign | Outbreak News Today says:

    […] doses have been shipped worldwide[9]. Bexsero was also recently provided in the US to students at Princeton University and the University of California, Santa Barbara (UCSB) under a treatment Investigational New […]

  3. Bexsero, meningitis B vaccine vaccination campaign results released - The Global Dispatch says:

    […] doses have been shipped worldwide[9]. Bexsero was also recently provided in the US to students at Princeton University and the University of California, Santa Barbara (UCSB) under a treatment Investigational New Drug […]

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Sign up for our Weekly Newsletter



Categories

Archives

At the Movies



Pin It